| Disaggregation of Revenue [Table Text Block] |
Disaggregated revenue by primary geographical markets and major goods and service lines are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Reportable Segments | | Three Months Ended | | April 5, 2026 | | March 30, 2025 | | Life Sciences | | Diagnostics | | Total | | Life Sciences | | Diagnostics | | Total | | (In thousands) | | Primary geographical markets | | | | | | | | | | | | | Americas | $ | 185,551 | | | $ | 130,441 | | | $ | 315,992 | | | $ | 184,279 | | | $ | 120,350 | | | $ | 304,629 | | | Europe | 91,695 | | | 131,351 | | | 223,046 | | | 76,022 | | | 105,770 | | | 181,792 | | | Asia | 84,599 | | | 87,481 | | | 172,080 | | | 80,094 | | | 98,247 | | | 178,341 | | | $ | 361,845 | | | $ | 349,273 | | | $ | 711,118 | | | $ | 340,395 | | | $ | 324,367 | | | $ | 664,762 | | | | | | | | | | | | | | | Major goods/service lines | | | | | | | | | | | | | Life Sciences Solutions | $ | 299,996 | | | $ | — | | | $ | 299,996 | | | $ | 286,453 | | | $ | — | | | $ | 286,453 | | | Software | 61,849 | | | — | | | 61,849 | | | 53,942 | | | — | | | 53,942 | | | Immunodiagnostics | — | | | 201,831 | | | 201,831 | | | — | | | 197,562 | | | 197,562 | | | Reproductive Health | — | | | 147,442 | | | 147,442 | | | — | | | 126,805 | | | 126,805 | | | $ | 361,845 | | | $ | 349,273 | | | $ | 711,118 | | | $ | 340,395 | | | $ | 324,367 | | | $ | 664,762 | |
|